BeOne Medicines AG (6160.HK) HKSE

183.50

-0.5(-0.27%)

Updated at December 24 12:08PM

Currency In HKD

BeOne Medicines AG

Address

Aeschengraben 27

Basel, MA 4051

Switzerland

Phone

41 61 685 19 00

Sector

Healthcare

Industry

Biotechnology

Employees

11000

First IPO Date

August 08, 2018

Key Executives

NameTitlePayYear Born
John V. OylerCo-Founder, Executive Chairman & Chief Executive Officer22.07M1968
Chan LeeGeneral Counsel & Senior Vice President8.37M1968
Wang LaiGlobal Head of Research & Development9.36M1977
Xiaobin WuPresident, Chief Operating Officer & GM of China14.3M1962
Aaron RosenbergChief Financial Officer15M1977
Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder33.06M1963
Marcello DamianiChief Technology Officer01970
Titus BallVP & Chief Accounting Officer01973
Eleanor DuffSenior VP & Head of Corporate Communications0N/A
Liza HeapesHead of Investor Relations0N/A

Description

BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.